These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

480 related articles for article (PubMed ID: 33414764)

  • 1. FGF19 and FGF21 for the Treatment of NASH-Two Sides of the Same Coin? Differential and Overlapping Effects of FGF19 and FGF21 From Mice to Human.
    Henriksson E; Andersen B
    Front Endocrinol (Lausanne); 2020; 11():601349. PubMed ID: 33414764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between Serum Atypical Fibroblast Growth Factors 21 and 19 and Pediatric Nonalcoholic Fatty Liver Disease.
    Alisi A; Ceccarelli S; Panera N; Prono F; Petrini S; De Stefanis C; Pezzullo M; Tozzi A; Villani A; Bedogni G; Nobili V
    PLoS One; 2013; 8(6):e67160. PubMed ID: 23840612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TCF7L2 transcriptionally regulates Fgf15 to maintain bile acid and lipid homeostasis through gut-liver crosstalk.
    Bhat N; Esteghamat F; Chaube BK; Gunawardhana K; Mani M; Thames C; Jain D; Ginsberg HN; Fernandes-Hernando C; Mani A
    FASEB J; 2022 Mar; 36(3):e22185. PubMed ID: 35133032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FGF19 and FGF21: In NASH we trust.
    Talukdar S; Kharitonenkov A
    Mol Metab; 2021 Apr; 46():101152. PubMed ID: 33383173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biological and pharmacological functions of the FGF19- and FGF21-coreceptor beta klotho.
    Aaldijk AS; Verzijl CRC; Jonker JW; Struik D
    Front Endocrinol (Lausanne); 2023; 14():1150222. PubMed ID: 37260446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rosuvastatin improves the FGF19 analogue NGM282-associated lipid changes in patients with non-alcoholic steatohepatitis.
    Rinella ME; Trotter JF; Abdelmalek MF; Paredes AH; Connelly MA; Jaros MJ; Ling L; Rossi SJ; DePaoli AM; Harrison SA
    J Hepatol; 2019 Apr; 70(4):735-744. PubMed ID: 30529590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tissue-specific expression of betaKlotho and fibroblast growth factor (FGF) receptor isoforms determines metabolic activity of FGF19 and FGF21.
    Kurosu H; Choi M; Ogawa Y; Dickson AS; Goetz R; Eliseenkova AV; Mohammadi M; Rosenblatt KP; Kliewer SA; Kuro-O M
    J Biol Chem; 2007 Sep; 282(37):26687-26695. PubMed ID: 17623664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FGF19 subfamily members: FGF19 and FGF21.
    Dolegowska K; Marchelek-Mysliwiec M; Nowosiad-Magda M; Slawinski M; Dolegowska B
    J Physiol Biochem; 2019 Jun; 75(2):229-240. PubMed ID: 30927227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FGF19, FGF21, and an FGFR1/β-Klotho-Activating Antibody Act on the Nervous System to Regulate Body Weight and Glycemia.
    Lan T; Morgan DA; Rahmouni K; Sonoda J; Fu X; Burgess SC; Holland WL; Kliewer SA; Mangelsdorf DJ
    Cell Metab; 2017 Nov; 26(5):709-718.e3. PubMed ID: 28988823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A long-acting FGF21 alleviates hepatic steatosis and inflammation in a mouse model of non-alcoholic steatohepatitis partly through an FGF21-adiponectin-IL17A pathway.
    Bao L; Yin J; Gao W; Wang Q; Yao W; Gao X
    Br J Pharmacol; 2018 Aug; 175(16):3379-3393. PubMed ID: 29859019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FGF21 acts as a negative regulator of bile acid synthesis.
    Chen MM; Hale C; Stanislaus S; Xu J; Véniant MM
    J Endocrinol; 2018 May; 237(2):139-152. PubMed ID: 29615519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opposite alterations in FGF21 and FGF19 levels and disturbed expression of the receptor machinery for endocrine FGFs in obese patients.
    Gallego-Escuredo JM; Gómez-Ambrosi J; Catalan V; Domingo P; Giralt M; Frühbeck G; Villarroya F
    Int J Obes (Lond); 2015 Jan; 39(1):121-9. PubMed ID: 24813368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential receptor selectivity of the FGF15/FGF19 orthologues determines distinct metabolic activities in
    Hansen AMK; Vienberg SG; Lykkegaard K; Zhao X; Tingqing G; Han D; Zhang X; Thøgersen H; Sass-Ørum K; Tagmose T; Raun K; Andersen B
    Biochem J; 2018 Sep; 475(18):2985-2996. PubMed ID: 30127091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibroblast growth factor 21 in non-alcoholic fatty liver disease.
    Tucker B; Li H; Long X; Rye KA; Ong KL
    Metabolism; 2019 Dec; 101():153994. PubMed ID: 31672443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fundamentals of FGF19 & FGF21 action in vitro and in vivo.
    Adams AC; Coskun T; Rovira AR; Schneider MA; Raches DW; Micanovic R; Bina HA; Dunbar JD; Kharitonenkov A
    PLoS One; 2012; 7(5):e38438. PubMed ID: 22675463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual actions of fibroblast growth factor 19 on lipid metabolism.
    Wu X; Ge H; Baribault H; Gupte J; Weiszmann J; Lemon B; Gardner J; Fordstrom P; Tang J; Zhou M; Wang M; Li Y
    J Lipid Res; 2013 Feb; 54(2):325-32. PubMed ID: 23204296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective Regulation of FGF19 and FGF21 Expression by Cellular and Nutritional Stress.
    Shimizu M; Morimoto H; Maruyama R; Inoue J; Sato R
    J Nutr Sci Vitaminol (Tokyo); 2015; 61(2):154-60. PubMed ID: 26052146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Enterokine Fibroblast Growth Factor 15/19 in Bile Acid Metabolism.
    Cariello M; Piglionica M; Gadaleta RM; Moschetta A
    Handb Exp Pharmacol; 2019; 256():73-93. PubMed ID: 31123830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of fibroblast growth factor 21 in the early stage of NASH induced by methionine- and choline-deficient diet.
    Tanaka N; Takahashi S; Zhang Y; Krausz KW; Smith PB; Patterson AD; Gonzalez FJ
    Biochim Biophys Acta; 2015 Jul; 1852(7):1242-52. PubMed ID: 25736301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relevant use of Klotho in FGF19 subfamily signaling system in vivo.
    Tomiyama K; Maeda R; Urakawa I; Yamazaki Y; Tanaka T; Ito S; Nabeshima Y; Tomita T; Odori S; Hosoda K; Nakao K; Imura A; Nabeshima Y
    Proc Natl Acad Sci U S A; 2010 Jan; 107(4):1666-71. PubMed ID: 20080590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.